Numerous studies have indicated that some antidiabetic medications are closely associated with the incidence of cancer.[53] Commonly used antidiabetic agents include sulfonylureas, thiazolidinediones, diguanidine, and insulin analogs, each of which has a different mechanism of action in vivo. This evidence concerns the gene INS and cancer.